Advertisement

Molecular Neurobiology

, Volume 53, Issue 7, pp 4745–4753 | Cite as

Tau Mislocation in Glucocorticoid-Triggered Hippocampal Pathology

  • Sara Pinheiro
  • Joana Silva
  • Cristina Mota
  • João Vaz-Silva
  • Ana Veloso
  • Vítor Pinto
  • Nuno Sousa
  • João Cerqueira
  • Ioannis Sotiropoulos
Article

Abstract

The exposure to high glucocorticoids (GC) triggers neuronal atrophy and cognitive deficits, but the exact cellular mechanisms underlying the GC-associated dendritic remodeling and spine loss are still poorly understood. Previous studies have implicated sustained GC elevations in neurodegenerative mechanisms through GC-evoked hyperphosphorylation of the cytoskeletal protein Tau while Tau mislocation has recently been proposed as relevant in Alzheimer’s disease (AD) pathology. In light of the dual cytoplasmic and synaptic role of Tau, this study monitored the impact of prolonged GC treatment on Tau intracellular localization and its phosphorylation status in different cellular compartments. We demonstrate, both by biochemical and ultrastructural analysis, that GC administration led to cytosolic and dendritic Tau accumulation in rat hippocampus, and triggered Tau hyperphosphorylation in epitopes related to its malfunction (Ser396/404) and cytoskeletal pathology (e.g., Thr231 and Ser262). In addition, we show, for the first time, that chronic GC administration also increased Tau levels in synaptic compartment; however, at the synapse, there was an increase in phosphorylation of Ser396/404, but a decrease of Thr231. These GC-triggered Tau changes were paralleled by reduced levels of synaptic scaffolding proteins such as PSD-95 and Shank proteins as well as reduced dendritic branching and spine loss. These in vivo findings add to our limited knowledge about the underlying mechanisms of GC-evoked synaptic atrophy and neuronal disconnection implicating Tau missorting in mechanism(s) of synaptic damage, beyond AD pathology.

Keywords

Tau Glucocorticoids Synaptic atrophy Neurodegeneration Hippocampus 

Abbreviations

GC

Glucocorticoids

MT

Microtubules

AD

Alzheimer’s disease

MWM

Morris water maze

PSD-95

Postsynaptic density protein 95

DEX

Dexamethasone

GluN2B

NMDA receptor 2B

GluA2

AMPA receptor 2

ANOVA

Analysis of variance

TEM

Transmission electron microscopy

Notes

Acknowledgments

We would like to thank Rui Fernandes for TEM technical support. IS was supported by the Portuguese Foundation for Science and Technology (FCT). This work was funded by the Portuguese Foundation for Science and Technology (FCT) (grant NMC-113934 to IS and grant SFRH/BPD/80118/2011 to JC), Canon Foundation and project DoIT - Desenvolvimento e Operacionalização da Investigação de Translação (N° do projeto 13853), funded by Fundo Europeu de Desenvolvimento Regional (FEDER) through the Programa Operacional Fatores de Competitividade (POFC).

Conflict of Interest

None of the authors report competing interests.

References

  1. 1.
    Cerqueira JJ, Pego JM, Taipa R, Bessa JM, Almeida OF, Sousa N (2005) Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J Neurosci 25(34):7792–7800. doi: 10.1523/JNEUROSCI.1598-05.2005 CrossRefPubMedGoogle Scholar
  2. 2.
    Soares JM, Sampaio A, Ferreira LM, Santos NC, Marques P, Marques F, Palha JA, Cerqueira JJ et al (2013) Stress impact on resting state brain networks. PLoS ONE 8(6):e66500. doi: 10.1371/journal.pone.0066500 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Sousa N, Almeida OF (2012) Disconnection and reconnection: the morphological basis of (mal)adaptation to stress. Trends Neurosci 35(12):742–751. doi: 10.1016/j.tins.2012.08.006 CrossRefPubMedGoogle Scholar
  4. 4.
    de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6(6):463–475. doi: 10.1038/nrn1683 CrossRefPubMedGoogle Scholar
  5. 5.
    Gotz J, Xia D, Leinenga G, Chew YL, Nicholas H (2013) What Renders TAU Toxic. Front Neurol 4:72. doi: 10.3389/fneur.2013.00072 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Frandemiche ML, De Seranno S, Rush T, Borel E, Elie A, Arnal I, Lante F, Buisson A (2014) Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. J Neurosci 34(17):6084–6097. doi: 10.1523/JNEUROSCI.4261-13.2014 CrossRefPubMedGoogle Scholar
  7. 7.
    Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 142(3):387–397. doi: 10.1016/j.cell.2010.06.036 CrossRefPubMedGoogle Scholar
  8. 8.
    Kimura T, Whitcomb DJ, Jo J, Regan P, Piers T, Heo S, Brown C, Hashikawa T et al (2014) Microtubule-associated protein tau is essential for long-term depression in the hippocampus. Philos Trans R Soc Lond B Biol Sci 369(1633):20130144. doi: 10.1098/rstb.2013.0144 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA et al (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68(6):1067–1081. doi: 10.1016/j.neuron.2010.11.030 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kimura T, Yamashita S, Fukuda T, Park JM, Murayama M, Mizoroki T, Yoshiike Y, Sahara N et al (2007) Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau. EMBO J 26(24):5143–5152. doi: 10.1038/sj.emboj.7601917 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT (2012) The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol 181(4):1426–1435. doi: 10.1016/j.ajpath.2012.06.033 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Zempel H, Luedtke J, Kumar Y, Biernat J, Dawson H, Mandelkow E, Mandelkow EM (2013) Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J 32(22):2920–2937. doi: 10.1038/emboj.2013.207 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Sotiropoulos I, Catania C, Pinto LG, Silva R, Pollerberg GE, Takashima A, Sousa N, Almeida OF (2011) Stress acts cumulatively to precipitate Alzheimer’s disease-like tau pathology and cognitive deficits. J Neurosci 31(21):7840–7847. doi: 10.1523/JNEUROSCI.0730-11.2011 CrossRefPubMedGoogle Scholar
  14. 14.
    Sotiropoulos I, Catania C, Riedemann T, Fry JP, Breen KC, Michaelidis TM, Almeida OF (2008) Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. J Neurochem 107(2):385–397. doi: 10.1111/j.1471-4159.2008.05613.x CrossRefPubMedGoogle Scholar
  15. 15.
    Cerqueira JJ, Taipa R, Uylings HB, Almeida OF, Sousa N (2007) Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. Cereb Cortex 17(9):1998–2006. doi: 10.1093/cercor/bhl108 CrossRefPubMedGoogle Scholar
  16. 16.
    Sahara N, Murayama M, Higuchi M, Suhara T, Takashima A (2014) Biochemical distribution of tau protein in synaptosomal fraction of transgenic mice expressing human P301L tau. Front Neurol 5:26. doi: 10.3389/fneur.2014.00026 PubMedPubMedCentralGoogle Scholar
  17. 17.
    Merino-Serrais P, Benavides-Piccione R, Blazquez-Llorca L, Kastanauskaite A, Rabano A, Avila J, DeFelipe J (2013) The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease. Brain 136(Pt 6):1913–1928. doi: 10.1093/brain/awt088 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Pooler AM, Usardi A, Evans CJ, Philpott KL, Noble W, Hanger DP (2012) Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol Aging 33(2):431. doi: 10.1016/j.neurobiolaging.2011.01.005, e427-438 CrossRefPubMedGoogle Scholar
  19. 19.
    Mondragon-Rodriguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N, Boehm J (2012) Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J Biol Chem 287(38):32040–32053. doi: 10.1074/jbc.M112.401240 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Campbell SN, Zhang C, Monte L, Roe AD, Rice KC, Tache Y, Masliah E, Rissman RA (2015) Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor. J Alzheimers Dis 43(3):967–976. doi: 10.3233/JAD-141281 PubMedPubMedCentralGoogle Scholar
  21. 21.
    Morris M, Maeda S, Vossel K, Mucke L (2011) The many faces of tau. Neuron 70(3):410–426. doi: 10.1016/j.neuron.2011.04.009 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Hall GF, Chu B, Lee G, Yao J (2000) Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease. J Cell Sci 113(Pt 8):1373–1387PubMedGoogle Scholar
  23. 23.
    Hall GF, Lee VM, Lee G, Yao J (2001) Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. Am J Pathol 158(1):235–246, doi: 10.1016/S0002-9440(10)63962-4 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Zempel H, Thies E, Mandelkow E, Mandelkow EM (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 30(36):11938–11950. doi: 10.1523/JNEUROSCI.2357-10.2010 CrossRefPubMedGoogle Scholar
  25. 25.
    Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N, Almeida OF (2009) The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry 14(1):95–105. doi: 10.1038/sj.mp.4002101 CrossRefPubMedGoogle Scholar
  26. 26.
    Sotiropoulos I, Silva J, Kimura T, Rodrigues AJ, Costa P, Almeida OF, Sousa N, Takashima A (2015) Female hippocampus vulnerability to environmental stress, a precipitating factor in tau aggregation pathology. J Alzheimers Dis 43(3):763–774. doi: 10.3233/JAD-140693 PubMedGoogle Scholar
  27. 27.
    Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, Mena R (2007) Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer’s disease. J Alzheimer’s Dis 12(4):365–375Google Scholar
  28. 28.
    Lauckner J, Frey P, Geula C (2003) Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging 24(6):767–776CrossRefPubMedGoogle Scholar
  29. 29.
    Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys 357(2):299–309. doi: 10.1006/abbi.1998.0813 CrossRefPubMedGoogle Scholar
  30. 30.
    Cho JH, Johnson GV (2004) Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau’s ability to bind and stabilize microtubules. J Neurochem 88(2):349–358CrossRefPubMedGoogle Scholar
  31. 31.
    Yoshiyama Y, Zhang B, Bruce J, Trojanowski JQ, Lee VM (2003) Reduction of detyrosinated microtubules and Golgi fragmentation are linked to tau-induced degeneration in astrocytes. J Neurosci 23(33):10662–10671PubMedGoogle Scholar
  32. 32.
    Sotiropoulos I, Cerqueira JJ, Catania C, Takashima A, Sousa N, Almeida OF (2008) Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer’s disease. Neurosci Biobehav Rev 32(6):1161–1173. doi: 10.1016/j.neubiorev.2008.05.007 CrossRefPubMedGoogle Scholar
  33. 33.
    Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model. Science 316(5825):750–754. doi: 10.1126/science.1141736 CrossRefPubMedGoogle Scholar
  34. 34.
    Miller EC, Teravskis PJ, Dummer BW, Zhao X, Huganir RL, Liao D (2014) Tau phosphorylation and tau mislocalization mediate soluble Abeta oligomer-induced AMPA glutamate receptor signaling deficits. Eur J Neurosci 39(7):1214–1224. doi: 10.1111/ejn.12507 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. J Neurosci 26(35):9047–9056. doi: 10.1523/JNEUROSCI.2797-06.2006 CrossRefPubMedGoogle Scholar
  36. 36.
    Takashima A, Noguchi K, Sato K, Hoshino T, Imahori K (1993) Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A 90(16):7789–7793CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    McKinney RA (2010) Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J Physiol 588(Pt 1):107–116. doi: 10.1113/jphysiol.2009.178905 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Sara Pinheiro
    • 1
    • 2
  • Joana Silva
    • 1
    • 2
  • Cristina Mota
    • 1
    • 2
  • João Vaz-Silva
    • 1
    • 2
  • Ana Veloso
    • 1
    • 2
  • Vítor Pinto
    • 1
    • 2
  • Nuno Sousa
    • 1
    • 2
  • João Cerqueira
    • 1
    • 2
  • Ioannis Sotiropoulos
    • 1
    • 2
  1. 1.Life and Health Sciences Research Institute (ICVS), School of Health SciencesUniversity of Minho, Campus GualtarBragaPortugal
  2. 2.ICVS/3B’s - PT Government Associate LaboratoryBraga/GuimarãesPortugal

Personalised recommendations